NEO - ネオス・ファ―マシュ―ティカルズ (NeoGenomics Inc.)

NEOのニュース

   NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition  2021/02/02 13:00:00 PR Newswire
/PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of NeoGenomics, Inc. (NASDAQ: NEO) and Tempus to…
   Bitcoin Holds Steady Above USD 30K, Ethereum and Altcoins Gain Traction  2021/01/28 13:21:04 cryptonews.com
Bitcoin price is stable above USD 30,500 and USD 31,000. BTC is currently (13:00 UTC) attempting an upside break above USD 31,800 and USD 32,000. A close above USD 32,000 could open the doors for a larger increase in the coming sessions. Besides, most major altcoins are showing signs of a fresh increase, including ethereum, EOS, XRP, XLM, LINK, BNB, OMG, NEO, TRX, bitcoin cash, DOT, litecoin, and
   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
   Routemaster Capital Graduates Public Listing to NEO Exchange  2021/01/21 15:27:00 Business Wire
TORONTO--(BUSINESS WIRE)-- #listing--Routemaster Capital Inc. (NEO:DEFI), a Canadian decentralized finance company, is now trading no NEO.
   A History of Price Movements for NEO - BeInCrypto  2021/01/19 15:26:05 BeInCrypto
While the NEO price has increased considerably since its March 2020 low, it's not even close to reaching its all-time high. NEO is unlike…
   China Stance on Crypto Remains The Same; Blockchain, Not Bitcoin  2020/12/04 19:39:08 BitcoinExchangeGuide
In a recent report by Chinese state media Xinhuanet, the Chinese government wants its citizens to stop paying attention to cryptocurrency but concentrate more on blockchain technology, the technology behind the cryptocurrencies. China is emphasizing that the current rise of almost all crypto coins could seem very attractive to investors, which may not be permanent. According to the media report, the warning is to protect the Chinese citizens and residents from making life-damaging investment decisions. However, it encourages citizens to invest more time and resources in Blockchain technology since it can be applied in various industries. The past few weeks had seen the upsurge of Bitcoin price, as it moved above its previous all-time high achieved in 2017 when it reached $20,000 per Bitcoin. The same story goes for other cryptocurrencies. Some even tripled in price, representing massive investment profits for the crypto holder. Bitcoin’s direction is uncertain Various market analysts have predicted on the recent Bull Run and where the market is headed next.
   Moonstake Collaboration Webinar: "The future of blockchain: the case of Neo3" - Stocks News Feed  2020/12/03 04:56:06 Stocks News Feed
SINGAPORE, Dec 3, 2020 – (ACN Newswire) – Moonstake will hold a joint webinar with NEO, “The future of blockchain: the case of NEO3” on 3rd of Dec, 2020. It will be held from 3PM Singapore/Beijing time. NEO, also known as Ethereum in China, launched the mainnet three years ago and has been in stable… Read More »Moonstake Collaboration Webinar: “The future of blockchain: the case of Neo3”
   Neo führt Kinder in die Digitalwelt  2020/12/02 15:25:35 W&V
Mit der Smartwatch von Disney und Vodafone kann der Nachwuchs Fotografieren, Bewegungen tracken - und natürlich mit den Eltern in Verbindung bleiben. Die behalten über eine App die volle Kontrolle.
   $NEO $NEOUSD #NEO - Daily  2020/12/02 14:47:38 CentralCharts
The bullish trend is currently very strong on NEO - NEO/USD. As long as the price remains above the support at 16.47 USD, you could try to benefit from the boom. The first bullish objective is located at 18.70 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 20.48 USD as an objective. Crossing it would then enable buyers to target 25.16 USD. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
   The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback  2020/11/25 12:35:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) AbbVie Inc (NYSE: ABBV ) Affimed NV (NASDAQ: AFMD ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cellectis SA (NASDAQ: CLLS ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Generation Bio Co (NASDAQ: GBIO ) Inspire Medical Systems Inc (NYSE: INSP ) Kronos Bio Inc (NASDAQ: KRON ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) NeoGenomics, Inc. (NASDAQ: NEO ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pulmonx Corp (NASDAQ: LUNG ) Relay Therapeutics Inc (NASDAQ: RLAY ) Sotera Health Co (NASDAQ: SHC ) (began trading on Nasdaq Friday following its IPO) Trinity Biotech plc (NASDAQ: TRIB ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 24) Advaxis, Inc. (NASDAQ: ADXS ) ( announced a public offering of common stock and warrants) Immunome Inc (NASDAQ: IMNM ) InMed Pharmaceuticals Inc (NASDAQ: INM ) Kiromic Biopharma Inc (NASDAQ: KRBP ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI ) debuted on Wall Street Friday) Qualigen …
   „Der Anbräuner“ : So antwortet Neo Rauch auf die Kritik eines Kunsthistorikers  2020/11/24 09:00:00 Mitteldeutsche Zeitung
   Karate Combat: na primeira ‘batalha brasileira’ da história da organização, Bruno Assis supera Teeik Silva  2020/11/23 12:45:43 Globo Jornal Extra
Destaque com três dos quatro lutadores em ação, o Brasil foi o grande protagonista da nona edição da temporada 2020 do Karate Combat. O evento aconteceu no último domingo (22) no cenário "Neo Tokyo", uma das temáticas futuristas geradas por… Leia mais
   NeoGenomics (NASDAQ:NEO) PT Raised to $50.00  2020/11/20 13:32:42 Transcript Daily
NeoGenomics (NASDAQ:NEO) had its price objective increased by stock analysts at SVB Leerink from $47.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. SVB Leerink’s target price points to a potential upside of 17.01% from […]
   NeoGenomics, Inc. (NASDAQ:NEO) Receives $40.68 Average PT from Analysts  2020/11/19 16:38:43 Transcript Daily
Shares of NeoGenomics, Inc. (NASDAQ:NEO) have earned an average rating of “Buy” from the fourteen analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year […]
   Investment Analysts’ Weekly Ratings Changes for NeoGenomics (NEO)  2020/11/16 19:32:44 Transcript Daily
A number of research firms have changed their ratings and price targets for NeoGenomics (NASDAQ: NEO): 11/2/2020 – NeoGenomics was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating. 10/28/2020 – NeoGenomics had its price target raised by analysts at Raymond James from $40.00 to $48.00. They now have an “outperform” […]

calendar